CGON 8-K 2026-01-13

CG Oncology, Inc. (CGON) 8-K dated 2026-01-13 — accession 0001193125-26-011855. This URL is the filing, not the CGON hub.

CG Oncology, Inc. (CGON) is a biotechnology company listed on US.

CG Oncology, Inc. filed a 8-K on 2026-01-13. Accession 0001193125-26-011855.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.

Not investment advice. The CGON SEC hub lists recent forms. The stock page is the research view.